Home
|
NRI
|
Business Associates
|
Knowledge Bank
|
Careers
|
Back Office
|
Contact Us
Get Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss Accounts
Quarterly Results
Key Financial Ratios
Share Price
Charts
Quarterly Results
Divis Laboratories Ltd
Industry
: Pharmaceuticals - Indian - Bulk Drugs
Chairman
: Ramesh B V Nimmagadda
Home
: Indian Private
Book Value
: 513.6236355
BSE Code
: 532488
Market Cap
: 156107.47
NSE Code
: DIVISLAB
P / E
: 84.98
Change Company :
Quarters:
3
4
5
6
7
8
(Rs in Cr.)
Quarterly Results
Particulars
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Type
2Qtr
1Qtr
4Qtr
3Qtr
Net Sales
2302.00
2063.00
2259.00
1808.00
Other Income
105.00
79.00
79.00
94.00
Total Income
2407.00
2142.00
2338.00
1902.00
Total Expenditure
1573.00
1442.00
1542.00
1317.00
Operating Profit
834.00
700.00
796.00
585.00
Interest
1.00
0.00
2.00
0.00
Gross Profit
833.00
700.00
794.00
585.00
Depreciation
98.00
97.00
94.00
95.00
Tax
218.00
178.00
159.00
121.00
Deferred Tax
-1.00
-5.00
10.00
11.00
Reported Profit After Tax
518.00
430.00
531.00
358.00
BSE Disclaimer
|
Disclaimer
|
Privacy Statement
|
Terms of Use
|
Feedback
|
Sitemap
|
Downloads
|
Client Bank Details
Useful Links
|
Risk Disclosure
|
Rules and Regulations
|
Investor Charter
|
Investor Complaints
|
Smart ODR
|
Attention Investors
|
SEBI Saa₹thi Mobile App/SEBI Investor Website
SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822
SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527
2006-07 © SSJ Finance & Securities Pvt. Ltd. All Rights Reserved
Developed & Maintained By
C-MOTS Infotech(ISO 9001:2015 certified)
Content powered by
Capital Market
Charts are powered by
TradingView